Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-025409

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Molineaux
Officer — SR. VP, DEVELOPMENT
Period of report
Jul 20, 2016
Accepted (ET)
Jul 21, 2016 · 7:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 20, 2016M7,586$0.96A10,086D
Common StockF1Jul 20, 2016M4,749$2.64A14,835D
Common StockF2holding———266,616IBy Trust
Common Stockholding———31,885IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$0.96Jul 20, 2016M7,586D—May 22, 2023Common Stock7,58611,920D
Employee Stock Option (Right to Buy)F4$2.64Jul 20, 2016M4,749D—Dec 16, 2023Common Stock4,74914,247D
Employee Stock Option (Right to Buy)F5$0.48Jul 20, 2016M4,410D—Jun 12, 2022Common Stock4,4100I
Employee Stock Option (Right to Buy)F3$0.96Jul 20, 2016M8,829D—May 22, 2023Common Stock8,82913,874I
Employee Stock Option (Right to Buy)F4$2.64Jul 20, 2016M16,146D—Dec 16, 2023Common Stock16,14647,919I

Explanation of responses